Corrigendum to “Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer” [604 (2024) 217219 1–12](S0304383524006141)(10.1016/j.canlet.2024.217219)

Abstract

The authors regret to report an error in our recently published article by Chica-Parrado et al. titled “Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer,” In this article, cropped images for Western blot loading controls were inadvertently duplicated in several figure panels (Fig. 3A, D, and 6F) during the process of figure preparation. On behalf of all co-authors, we would like to submit a corrigendum to correct these errors. The corrected versions of these 3 figure panels are attached below for your review.[Figure presented][Figure presented][Figure presented] The authors would like to apologise for any inconvenience caused.[Figure presented]